Prognostic value of ATN Alzheimer biomarkers: 60‐month follow‐up results from the Argentine Alzheimer's Disease Neuroimaging Initiative-Reference-Cited by-同舟云学术

Prognostic value of ATN Alzheimer biomarkers: 60‐month follow‐up results from the Argentine Alzheimer's Disease Neuroimaging Initiative

Published:2020-01 Issue:1 Volume:12 Page:
ISSN:2352-8729
Container-title:Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
language:en
Short-container-title:Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring

Author:

Allegri Ricardo F.¹²,Chrem Méndez Patricio¹,Calandri Ismael¹,Cohen Gabriela¹,Martín Maria Eugenia¹,Russo María Julieta¹,Crivelli Lucia¹,Pertierra Lucia¹,Tapajóz Fernanda¹,Clarens María Florencia¹,Campos Jorge¹,Nahas Federico E.¹,Vázquez Silvia³,Surace Ezequiel⁴,Sevlever Gustavo⁴

Affiliation:

1. Department of Cognitive Neurology Neuropsychiatry and Neuropsychology, Instituto de Investigaciones Neurológicas FLENI Buenos Aires Argentina

2. Department of Neurosciences Universidad de la Costa (CUC) Barranquilla Colombia

3. Center of Molecular Neuroimaging Instituto de Investigaciones Neurológicas FLENI Buenos Aires Argentina

4. Department of Molecular Biology and Neuropathology Instituto de Investigaciones Neurológicas FLENI Buenos Aires Argentina

Publisher

Wiley

Subject

Psychiatry and Mental health,Clinical Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/dad2.12026

Reference38 articles.

1. Amyloid-β and Tau

2. Argentina‐Alzheimer's disease neuroimaging initiative. Creation of the Argentina—Alzheimer Disease Neuroimaging Initiative;Russo MJ;Alzheimers Dement,2014

3. Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

4. The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

5. An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancements in dementia research, diagnostics, and care in Latin America: Highlights from the 2023 Alzheimer's Association International conference satellite symposium in Mexico City;Alzheimer's & Dementia;2024-05-27

2. Cerebrospinal fluid reference proteins increase accuracy and interpretability of biomarkers for brain diseases;Nature Communications;2024-05-01

3. Reflections from the OARSI 2022 clinical trials symposium: The pain of OA—Deconstruction of pain and patient-reported outcome measures for the benefit of patients and clinical trial design;Osteoarthritis and Cartilage;2023-10

4. COVID-19 and Alzheimer's Disease: Neuroinflammation, Oxidative Stress, Ferroptosis, and Mechanisms Involved;Current Medicinal Chemistry;2023-10

5. Alzheimer's disease diagnostic accuracy by fluid and neuroimaging ATN framework;CNS Neuroscience & Therapeutics;2023-07-12